Table 3.
Stage | Death | Local recurrence | Distant metastasis | |||
Event/N | 5-year OS (%) | Event/N | 5-year LRFS (%) | Event/N | 5-year DMFS (%) | |
T1N0 | 1/60 | 97.8 | 0/60 | 100 | 2/60 | 96.6 |
T2N0 | 0/16 | 100 | 1/16 | 92.9 | 1/16 | 90.9 |
T3N0 | 1/16 | 93.8 | 0/16 | 100 | 0/16 | 100 |
T4N0 | 4/18 | 76.9 | 2/18 | 88.9 | 1/18 | 93.3 |
OS, overall survival; LRFS, local relapse-free survival; DMFS, distant metastasis-free survival